Literature DB >> 6411898

Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid.

H A Singer, M J Peach.   

Abstract

Vascular responses to the addition of arachidonic acid (AA) were characterized in rings of rabbit thoracic aorta. In preparations which were precontracted to a stable plateau by 10(-7) M phenylephrine, AA (10-100 microM) elicited transient relaxation if the endothelium was intact. The same concentrations of AA only contracted tissues in which the endothelium was purposely disrupted. Indomethacin pretreatment (14 microM, 30 min) potentiated the relaxation response in intact rings. Under these conditions, relaxation in response to 100 microM AA was 32(+/- 3)% of the tension stimulated by 10(-7) M phenylephrine. Preincubation with 5,8,11,14-eicosatetraynoic acid (50 microM) or nordihydroguaiaretic acid (25 microM) completely prevented AA-induced relaxation. Contractile responses to AA were examined in rings lacking pre-existing active tension. AA (3-100 microM) elicited rapidly developing and somewhat transient contractions in rings with endothelium. Slow developing contractions which were significantly smaller in magnitude were observed in rings lacking endothelium. Indomethacin or 5,8,11,14-eicosatetraynoic acid pretreatment inhibited AA-stimulated contractions both in intact and de-endothelialized tissues. Nordihydroguaiaretic acid pretreatment had no effect on contractile responses in rings lacking endothelium and slightly potentiated responses in intact rings. We conclude that endothelium-dependent relaxation of rabbit aorta by AA is mediated by a noncyclooxygenase metabolite(s). Contractile responses are mediated by cyclooxygenase metabolites, which in intact rings are derived largely from the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411898

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

1.  Cooling and response to adrenoceptor agonists of rabbit ear and femoral artery: role of the endothelium.

Authors:  A L García-Villalón; L Monge; J J Montoya; J L García; N Fernández; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

Review 2.  Raynaud's syndrome.

Authors:  E D Cooke; A N Nicolaides
Journal:  BMJ       Date:  1990-03-03

3.  Effects of prostaglandin I2 synthesized in the endothelium and in the smooth muscle on mechanical properties of the canine thoracic aorta.

Authors:  M Domae; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

4.  Vicious circles in reflex sympathetic dystrophy--a hypothesis: discussion paper.

Authors:  E D Cooke; C Ward
Journal:  J R Soc Med       Date:  1990-02       Impact factor: 5.344

5.  Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.

Authors:  M Rademaker; E D Cooke; N E Almond; J A Beacham; R E Smith; T G Mant; J D Kirby
Journal:  BMJ       Date:  1989-03-04

6.  Endothelium-dependent relaxation is independent of arachidonic acid release.

Authors:  P G Milner; N J Izzo; J Saye; A L Loeb; R A Johns; M J Peach
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

7.  Vasoactive effects of eicosapentaenoic acid on isolated vascular smooth muscle.

Authors:  A Yanagisawa; A M Lefer
Journal:  Basic Res Cardiol       Date:  1987 Mar-Apr       Impact factor: 17.165

8.  Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation.

Authors:  V L Brashers; M J Peach; C E Rose
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 9.  Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.

Authors:  William B Campbell; Kathryn M Gauthier
Journal:  J Cardiovasc Pharmacol       Date:  2013-03       Impact factor: 3.105

10.  Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitors.

Authors:  K Ryoyama; T Nomura; S Nakamura
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.